Cyta Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Cyta Therapeutics General Information

Description

Operator of a pre-clinical stage therapeutics company intended to develop small molecule candidates for treating liver diseases. The company is based on a novel chemistry platform that develops drug delivery services and focuses on polymer-based nano gels that reduce tissue inflammation and stimulate tissue regeneration in the liver, and develops proprietary products to treat obesity and related metabolic conditions, enabling healthcare professionals to get potent drug assets with increased safety and efficacy.

Contact Information

Website
www.cytatx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 110 Canal Street Floor 4
  • Suite 4
  • Lowell, MA 01852
  • United States
+1 (617)
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Vertical(s)
Nanotechnology, Life Sciences
Corporate Office
  • 110 Canal Street Floor 4
  • Suite 4
  • Lowell, MA 01852
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cyta Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-Feb-2024 Completed Generating Revenue
2. Early Stage VC 20-Jul-2016 Completed Generating Revenue
1. University Spin-Out 01-Jan-2015 Completed Startup
To view Cyta Therapeutics’s complete valuation and funding history, request access »

Cyta Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pre-clinical stage therapeutics company intended to develop small molecule candidates for treating liver d
Drug Delivery
Lowell, MA
2 As of 2023

South San Francisco, CA
 

Loos, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cyta Therapeutics Competitors (20)

One of Cyta Therapeutics’s 20 competitors is NGM Biopharmaceuticals, a Private Equity-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NGM Biopharmaceuticals Private Equity-Backed South San Francisco, CA
Genfit Formerly VC-backed Loos, France
Abivax Formerly PE-Backed Paris, France
Altimmune Formerly VC-backed Gaithersburg, MD
Akero Therapeutics Corporate Backed or Acquired South San Francisco, CA
You’re viewing 5 of 20 competitors. Get the full list »

Cyta Therapeutics Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Cyta Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4373476-A1 Particle delivery of thyroid hormone receptor agonists and antagonists Inactive 21-Jul-2021
US-20250000836-A1 Particle delivery of thyroid hormone receptor agonists and antagonists Pending 21-Jul-2021
WO-2023004002-A1 Particle delivery of thyroid hormone receptor agonists and antagonists Inactive 21-Jul-2021
WO-2017139212-A1 Particle delivery of rapamycin to the liver Inactive 08-Feb-2016
WO-2017100597-A1 Particle delivery of prostaglandin receptor agonists and antagonists Inactive 11-Dec-2015 A61K31/5578
To view Cyta Therapeutics’s complete patent history, request access »

Cyta Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cyta Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Innovation Space Accelerator/Incubator Minority
UMass Lowell University Minority
University of Massachusetts Amherst University
To view Cyta Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Cyta Therapeutics FAQs

  • When was Cyta Therapeutics founded?

    Cyta Therapeutics was founded in 2015.

  • Where is Cyta Therapeutics headquartered?

    Cyta Therapeutics is headquartered in Lowell, MA.

  • What is the size of Cyta Therapeutics?

    Cyta Therapeutics has 2 total employees.

  • What industry is Cyta Therapeutics in?

    Cyta Therapeutics’s primary industry is Drug Delivery.

  • Is Cyta Therapeutics a private or public company?

    Cyta Therapeutics is a Private company.

  • What is Cyta Therapeutics’s current revenue?

    The current revenue for Cyta Therapeutics is .

  • Who are Cyta Therapeutics’s investors?

    The Innovation Space, UMass Lowell, and University of Massachusetts Amherst have invested in Cyta Therapeutics.

  • Who are Cyta Therapeutics’s competitors?

    NGM Biopharmaceuticals, Genfit, Abivax, Altimmune, and Akero Therapeutics are some of the 20 competitors of Cyta Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process